Individuals enrolled in Apple Health (Medicaid), Public Employees Benefits Board, and School Employees Benefits Board coverage - and those accessing behavioral health services - will not experience a disruption in care due to the federal government shutdown. In addition, health care providers will continue to be paid for the services they provide. We will continue to monitor the situation closely and share updates if anything changes.
Treatments to include in review for patients with chondral defects of the knee would be matrix-induced autologous chondrocyte implantation (MACI), autologous chondrocyte implantation (ACI), microfracture surgery, and osteochondral autologous transplantation (OATS) as potential alternatives to surgical knee cartilage repair strategy.
Osteochondral Autograft Transfer System surgery (OATS) was first reviewed by the HTCC in 2011.
Status: Decision complete
Significant questions remain about the safety, efficacy, and effectiveness, and cost effectiveness of OATS/mosaicplasty cartilage surgery, MACI, ACI, and microfracture surgery.
| Type | Materials |
|---|---|
| Assessment (2024) | |
| Update literature for OATS (2018) | |
| Assessment on OATS (2011) |
Assessment timeline
